Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01440933Phase 2Completed
A Phase 2 trial of Sugammadex in neuromuscular blockade (NMB). Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01440933.